90 related articles for article (PubMed ID: 3906228)
21. Early in vitro detection of interleukin-2-like activities by pretreatment with allogeneic blood lymphocytes in miniature swine.
Taura Y; Mullen Y; Papoian T; Tsunoda T; Shiogama T
J Vet Med Sci; 1991 Jun; 53(3):365-9. PubMed ID: 1832023
[TBL] [Abstract][Full Text] [Related]
22. Pretransplant CD4 helper function and interleukin 10 response predict risk of acute kidney graft rejection.
Weimer R; Zipperle S; Daniel V; Carl S; Staehler G; Opelz G
Transplantation; 1996 Dec; 62(11):1606-14. PubMed ID: 8970616
[TBL] [Abstract][Full Text] [Related]
23. Immunosuppressive T-cell antibody induction for heart transplant recipients.
Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
Cochrane Database Syst Rev; 2013 Dec; (12):CD008842. PubMed ID: 24297433
[TBL] [Abstract][Full Text] [Related]
24. Study of the cytokine polymorphisms in correlation to rejection and graft survival in renal allograft donors and recipients from a homogenous Saudi population.
Gaafar A; Iqniebi A; Sheereen A; Eldali A; Turpeinen H; Adra C; Al Meshari K; Al Hussein K
Transpl Immunol; 2014 Jan; 30(1):34-9. PubMed ID: 24316141
[TBL] [Abstract][Full Text] [Related]
25. Analysis of cytokine gene polymorphisms in recipient's matched with living donors on acute rejection after renal transplantation.
Manchanda PK; Mittal RD
Mol Cell Biochem; 2008 Apr; 311(1-2):57-65. PubMed ID: 18165865
[TBL] [Abstract][Full Text] [Related]
26. Allo-specific immune response profiles indicative of acute rejection in kidney allografts using an in vitro lymphocyte culture-based model.
Mahakur S; Saikia B; Minz M; Minz RW; Nada R; Anand S; Sharma A; Jha V; Joshi N; Goel L; Arora A; Joshi K
Clin Exp Nephrol; 2018 Apr; 22(2):465-473. PubMed ID: 28849286
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 2, interferon, and lymphotoxin in renal transplant recipients.
McKenna RM; Rush DN; Bakkestad-Legare P; Jeffery JR
Transplantation; 1988 Jan; 45(1):76-81. PubMed ID: 3122387
[TBL] [Abstract][Full Text] [Related]
28. The effects of donor-specific blood transfusion enhancement of rat renal allografts on cytotoxic activity and phenotypes of peripheral blood lymphocytes, splenocytes, and graft-infiltrating cells.
Wasowska B; Baldwin WM; Howell DN; Sanfilippo F
Transplantation; 1991 Feb; 51(2):451-9. PubMed ID: 1994542
[TBL] [Abstract][Full Text] [Related]
29. Cytokine and cytotoxic molecule gene expression determined in peripheral blood mononuclear cells in the diagnosis of acute renal rejection.
Dugré FJ; Gaudreau S; Belles-Isles M; Houde I; Roy R
Transplantation; 2000 Oct; 70(7):1074-80. PubMed ID: 11045645
[TBL] [Abstract][Full Text] [Related]
30. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group.
Kahan BD; Rajagopalan PR; Hall M
Transplantation; 1999 Jan; 67(2):276-84. PubMed ID: 10075594
[TBL] [Abstract][Full Text] [Related]
31. Pre-transplant plasma and cellular levels of CD44 correlate with acute renal allograft rejection.
Rouschop KM; Roelofs JJ; Rowshani AT; Leemans JC; van der Poll T; Ten Berge IJ; Weening JJ; Florquin S
Nephrol Dial Transplant; 2005 Oct; 20(10):2248-54. PubMed ID: 16166750
[TBL] [Abstract][Full Text] [Related]
32. Serum level of soluble fibrinogen-like protein 2 in renal allograft recipients with acute rejection: a preliminary study.
Zhao Z; Yang C; Tang Q; Zhao T; Jia Y; Ma Z; Rong R; Xu M; Zhu T
Transplant Proc; 2012 Dec; 44(10):2982-5. PubMed ID: 23195010
[TBL] [Abstract][Full Text] [Related]
33. Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection.
Boleslawski E; Conti F; Sanquer S; Podevin P; Chouzenoux S; Batteux F; Houssin D; Weill B; Calmus Y
Transplantation; 2004 Jun; 77(12):1815-20. PubMed ID: 15223897
[TBL] [Abstract][Full Text] [Related]
34. Specific suppression of interleukin 2 biosynthesis by synthetic antisense oligodeoxynucleotides does not influence allograft rejection.
Yun S; Sawyer GJ; Zhang X; Gustafsson K; Fabre JW
Transplantation; 2000 Jun; 69(12):2586-92. PubMed ID: 10910281
[TBL] [Abstract][Full Text] [Related]
35. Direct cell mediated lympholysis by peripheral blood lymphocytes from renal allograft recipients.
Grunnet N; Kristensen T
Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):41-4. PubMed ID: 133456
[TBL] [Abstract][Full Text] [Related]
36. TNF-alpha, IL-6, IFN-gamma, and IL-10 gene expression polymorphisms and the IL-4 receptor alpha-chain variant Q576R: effects on renal allograft outcome.
Hahn AB; Kasten-Jolly JC; Constantino DM; Graffunder E; Singh TP; Shen GK; Conti DJ
Transplantation; 2001 Aug; 72(4):660-5. PubMed ID: 11544427
[TBL] [Abstract][Full Text] [Related]
37. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
[TBL] [Abstract][Full Text] [Related]
38. IL2-IL21 gene cluster polymorphism is not associated with allograft function after kidney transplantation.
Kwiatkowska E; Domanski L; Kłoda K; Pawlik A; Safranow K; Ciechanowski K
Int Urol Nephrol; 2014 Dec; 46(12):2415-20. PubMed ID: 25377634
[TBL] [Abstract][Full Text] [Related]
39. Analysis of fine-needle aspiration biopsies by flow cytometry in kidney transplant patients.
Oliveira JG; Ramos JP; Xavier P; Magalhães MC; Mendes AA; Guerra LE
Transplantation; 1997 Jul; 64(1):97-102. PubMed ID: 9233708
[TBL] [Abstract][Full Text] [Related]
40. [The effect of rejection crises and immunosuppressive therapy on the lymphocyte subpopulations of patients after kidney transplantation].
Kiparski Av; Frei D; Fierz W; Frei G; Uhlschmid G; Largiader F; Binswanger U
Klin Wochenschr; 1990 Apr; 68(8):408-14. PubMed ID: 1971857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
